Melanocytic atypia in dysplastic nevi.Immunohistochemical and cytophotometrical analysis
- 15 April 1988
- Vol. 61 (8) , 1660-1666
- https://doi.org/10.1002/1097-0142(19880415)61:8<1660::aid-cncr2820610825>3.0.co;2-x
Abstract
In a double-blind study a correlation was found between the histologically assessed degree of nevomelanocytic atypia in 58 dysplastic nevi (DN) and the presence of two markers associated with malignant transformation. The markers included a marked expression of histocompatibility locus Class I antigens on nevomelanocytes (P < 0.01) and abnormalities in the nuclear DNA content as measured by DNA cytophotometry (P = 0.01). Both markers were present in most of the markedly atypical DN, in about half of the moderately atypical DN, and in less than 30% of the mildly atypical DN. These findings suggest that a DN with marked or moderate melanocytic atypia indicates a premalignant condition and identifies a patient at risk for melanoma.This publication has 29 references indexed in Scilit:
- Phenotypic dynamics of tumor progression in human malignant melanomaInternational Journal of Cancer, 1985
- Acquired Precursors of Cutaneous Malignant MelanomaNew England Journal of Medicine, 1985
- Precursors to Malignant MelanomaPublished by American Medical Association (AMA) ,1984
- MANAGING THE DYSPLASTIC NAEVUS SYNDROMEThe Lancet, 1984
- A study of tumor progression: The precursor lesions of superficial spreading and nodular melanomaPublished by Elsevier ,1984
- MANAGING THE DYSPLASTIC NAEVUSThe Lancet, 1983
- DYSPLASTIC NAEVI AND CUTANEOUS MELANOMA RISKThe Lancet, 1983
- The dysplastic nevus syndrome Our definitionThe American Journal of Dermatopathology, 1982
- WHICH MOLES MATTER? THE ASSOCIATION BETWEEN MELANOCYTIC NAEVI AND MALIGNANT MELANOMATABritish Journal of Dermatology, 1981
- Dysplastic nevus syndrome: A phenotypic association of sporadic cutaneous melanomaCancer, 1980